Roger Zan

Roger Zan is a Partner at Guidehouse in the Life Sciences Practice, bringing over 20 years of experience in the pharmaceutical, biotech, and medical device sectors. They specialize in commercial strategy across various therapeutic areas, from chronic diseases to rare conditions. Prior to their current role, Roger held leadership positions at Novo Nordisk Inc. and Johnson & Johnson (Ethicon), where they were instrumental in launching diabetes products and developing marketing strategies for medical technologies. Roger is currently pursuing an MBA at Columbia University and holds a BA in Economics from The University of British Columbia.